Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres

Journal of Physiology

Volumn 593, Issue 12, 2015, Pages 2679-2692

  Boncompagni, Simona ^a   Arthurton, Lewis ^b   Akujuru, Eugene ^c   Pearson, Timothy ^c   Steverding, Dietmar ^c   Protasi, Feliciano ^a   Mutungi, Gabriel ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; GLUCOCORTICOID RECEPTOR; LAMININ; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RECEPTOR ANTIBODY; STRESS ACTIVATED PROTEIN KINASE; BECLOMETASONE; GLUCOCORTICOID;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; EXTRACELLULAR MATRIX; INTRACELLULAR SIGNALING; MALE; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; DRUG EFFECTS; METABOLISM; SKELETAL MUSCLE CELL;

ANIMALS; BECLOMETHASONE; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; EXTRACELLULAR MATRIX; GLUCOCORTICOIDS; MALE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE FIBERS, SKELETAL; MYOBLASTS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84931575301     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270502     Document Type: Article

References (45)

1. Alangari AA (2010). Genomic and non-genomic actions of glucocorticoids in asthma. Ann Thorac Med 5, 133-139.
2. Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D, Bienert M, Radbruch A, Burmester GR, Lauster R, Scheffold A & Buttgereit F (2004). Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J 18, 70-80.
3. Bennett AM & Tonks NK (1997). Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291.
4. Boncompagni S, Rossi AE, Micaroni M, Beznoussenko GV, Polishchuk RS, Dirksen RT & Protasi F (2009). Mitochondria are linked to calcium stores in striated muscle by developmentally regulated tethering structures. Mol Biol Cell 20, 1058-1067.
5. Bruna A, Nicolas M, Munoz A, Kyriakis JM & Caelles C (2003). Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22, 6035-6044.
6. + ions into concanavalin A-stimulated thymocytes. Biochem J 326, 329-332.
7. Caelles C, González-Sancho JM & Muñoz A (1997). Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 11, 3351-3364.
8. Croxtall JD, Choudhury Q & Flower RJ (2000). Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130, 289-298.
9. Cuenda A & Cohen P (1999). Stress-activated protein kinase-2 p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 274, 4341-4346.
10. De Beer FC, Baltz ML, Holford S, Feinstein A & Pepys MB (1981). Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med 154, 1134-1149.
11. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
12. Franklin CC & Kraft AS (1997). Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272, 16917-16923.
13. Gametchu B, Watson CS & Wu SH (1993). Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J 7, 1283-1292.
14. Gawlik KI & Durbeej M (2011). Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle 1, 9.
15. Goldberg AL (1969). Protein turnover in skeletal muscle. 2. Effects of denervation and cortisone on protein catabolism in skeletal muscle. J Biol Chem 244, 3223-3229.
16. González MV, Jiménez B, Berciano MT, González-Sancho JM, Caelles C, Lafarga M & Muñoz A (2000). Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution. J Cell Biol 150, 1199-1207.
17. Gutièrrez-Mecinas M, Trollope AF, Collins A, Morfett H, Hesketh SA, Kersanté F & Reul JM (2011). Long-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling. Proc Natl Acad Sci U S A 108, 13806-13811.
18. Hafezi-Moghadam A, Simoncini T, Yang ZQ, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K & Liao JK (2002). Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8, 473-479.
19. Hamdi M & Mutungi G (2010). Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres. J Physiol 588, 511-525.
20. Hamdi M & Mutungi G (2011). Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J Physiol 589, 3623-3640.
21. Hua SY & Chen YZ (1989). Membrane receptor-mediated electrophysiological effects of glucocorticoid on mammalian neurons. Endocrinology 124, 687-691.
22. Imasato A, Desbois-Mouthon C, Han JH, Kai H, Cato ACB, Akira S & Li JD (2002). Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem 277, 47444-47450.
23. Jones NC, Tyner KJ, Nibarger L, Stanley HM, Cornelison DDW, Fedorov YV & Olwin BB (2005). The p38α/β MAPK functions as a molecular switch to activate the quiescent satellite cell. J Cell Biol 169, 105-116.
24. Kadmiel M & Cidlowski JA (2013). Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci 34, 518-530.
25. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M & Cato ACB (2001). Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20, 7108-7116.
26. Krieger DT, Allen W, Rizzo F & Krieger HP. (1971). Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32, 266-284.
27. Lasa M, Abraham SM, Boucheron C, Saklatvala J & Clark AR (2002). Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22, 7802-7811.
28. Li X, Qiu J, Wang J, Zhong Y, Zhu J & Chen Y (2001). Corticosterone-induced rapid phosphorylation of p38 and JNK mitogen-activated protein kinases in PC12 cells. FEBS Lett 492, 210-214.
29. Lipworth BJ (2000). Therapeutic implications of non-genomic glucocorticoid activity. Lancet 356, 87-89.
30. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J & Salehian B (2003). Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285, E363-E371.
31. Moore RL & Stull JT (1984). Myosin light chain phosphorylation in fast and slow skeletal-muscles in situ. Am J Physiol 247, C462-C471.
32. Nava S, Gayan-Ramirez G, Rollier H, Bisschop A, Dom R, de Bock V & Decramer M (1996). Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med 153, 1888-1896.
33. Orchinik M, Murray TF & Moore FL (1991). A corticosteroid receptor in neuronal membranes. Science 252, 1848-1851.
34. Pasquini F, Guerin C, Blake D, Davies K, Karpati G & Holland P (1995). The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal-muscle satellite cells. Neuromuscul Disord 5, 105-114.
35. Pérez MH-A, Cormack J, Mallinson D & Mutungi G (2013). A membrane glucocorticoid receptor mediates the rapid/non-genomic actions of glucocorticoids in mammalian skeletal muscle fibres. J Physiol 591, 5171-5185.
36. Pratt WB & Toft DO (2003). Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228, 111-133.
37. Qi AQ, Qiu J, Xiao L & Chen YZ (2005). Rapid activation of JNK and p38 by glucocorticoids in primary cultured hippocampal cells. J Neurosci Res 80, 510-517.
38. Rannels SR & Jefferson LS (1980). Effects of glucocorticoids on muscle protein-turnover in perfused rat hemicorpus. Am J Physiol 238, E564-E572.
39. Sklar RM & Brown RH (1991). Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro. J Neurol Sci 101, 73-81.
40. Stahn C & Buttgereit F (2008). Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 4, 525-533.
41. van Balkom RHH, van der Heijden HFM, van Moerkerk HTB, Veerkamp JH, Fransen JAM, Ginsel LA, Folgering HTM, van Herwaarden CLA & Dekhuijzen PNR (1996). Effects of different treatment regimens of methylprednisolone on rat diaphragm contractility, immunohistochemistry and biochemistry. Eur Respir J 9, 1217-1223.
42. Weston AD, Sampaio AV, Ridgeway AG & Underhill TM (2003). Inhibition of p38 MAPK signaling promotes late stages of myogenesis. J Cell Sci 116, 2885-2893.
43. Widegren U, Wretman C, Lionikas A, Hedin G & Henriksson J (2000). Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pflugers Arch 441, 317-322.
44. Wing SS & Goldberg AL (1993). Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal-muscle during fasting. Am J Physiol 264, E668-E676.
45. Yu M, Blomstrand E, Chibalin AV, Krook A & Zierath Jr. (2001). Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. J Physiol 536, 273-282.